AI Pharma Innovation: Clinical Development

AI Pharma Innovation: Clinical Development is organized by Hanson Wade and will be held from Jul 24 - 26, 2018 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Optimize Your Trial Design, Biomarker Identification and Improve Patient Selection to Deliver More Effective, Value-Based & Precision Medicines to Market

As clinical failure rates remain unsustainable, the inaugural AI Pharma Innovation: Clinical Development Summit is committed to help large pharma, biotech and artificial intelligence innovators overcome key strategic and technical challenges of integrating the right AI solution and applying it specifically to maximize and accelerate clinical development.

The AI Pharma Innovation: Clinical Development Summit will bring together the leading scientists, technology developers, & key decision makers in the pharmaceutical and biotechnology industries.

As part of the AI Pharma Innovation Series 2018, the only set of conferences solely dedicated to accelerating the effective adoption and successful application of AI and machine learning technologies at specific points of the pharmaceutical value chain, join the AI Pharma Innovation: Clinical Development Summit to discover how to harness AI to enhance trial design, improve patient selection, identify biomarkers for precision medicine development and optimize pharmacovigilance studies.

Price:
Conference + 2 Workshops Earlybird (Book by 25/05/18): USD 3297.0
Conference + 1 Workshop Earlybird (Book by 25/05/18): USD 2798.0
Conference Earlybird (Book by 25/05/18): USD 2299.0
Conference (Standard rate): USD 2799.0

Speakers:Raj Bandaru (Sanofi), Alex Zhavoronkov (InSilico Medicine), Haoda Fu (Eli Lilly), Gregory V. Goldmacher (Merck), Arun Asaithambi (Lantern Pharma), Shanrong Zhao (Pfizer), Edward Bowen (GSK), Ray Liu (Takeda), Leonardo Rodrigues (Berg)

Additional details will be posted as soon as they are available.